Clinical value of systemic symptoms in IgA nephropathy with ANCA positivity
Clinical Rheumatology Dec 07, 2017
Xie L, et al. - Regarding the clinical utility of systemic symptoms in IgA nephropathy (IgAN) with anti-neutrophil cytoplasmic antibodies (ANCA) positivity, this study reports that the pathogenic role of ANCA in patients with IgAN can be predicted via evaluation of systemic symptoms, which represents a simple, readily available clinical tool for this purpose in this group of patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries